The Role of the Microbiome and Intestinal Mucosal Barrier in the Development and Progression of Non-Alcoholic Fatty Liver Disease

The Role of the Microbiome and Intestinal Mucosal Barrier in the Development and Progression of Non-Alcoholic Fatty Liver Disease

Aim. To review available data on the role of the microbiome and intestinal mucosal barrier in the development and progression of non-alcoholic fatty liver disease (NAFLD).Key points. The role of the human microbiome in the development and progression of NAFLD is associated with its effects on the ri...

Full description

Bibliographic Details
Main Authors:	T. S. Krolevets, M. A. Livzan, S. I. Mozgovoy
Format:	Article
Language:	Russian
Published:	Gastro LLC 2020-12-01
Series:	Российский журнал гастроэнтерологии, гепатологии, колопроктологии
Subjects:	intestinal mucosal barrier non-alcoholic fatty liver disease fibrosis microbiota
Online Access:	https://www.gastro-j.ru/jour/article/view/530

Similar Items

Features of intestinal microbiota disorders in the development of metabolic disorders in non-alcoholic fatty liver disease
by: M. A. Livzan, et al.
Published: (2021-02-01)

Berberine ameliorates intestinal mucosal barrier dysfunction in nonalcoholic fatty liver disease (NAFLD) rats
by: Yuzhen Wang, et al.
Published: (2020-07-01)

Disrupted intestinal mucosal barrier mediated by alcohol consumption aggravates systemic microplastic accumulation
by: Su-Min Baek, et al.
Published: (2023-09-01)

<i>Lactobacillus plantarum</i> MA2 Ameliorates Methionine and Choline-Deficient Diet Induced Non-Alcoholic Fatty Liver Disease in Rats by Improving the Intestinal Microecology and Mucosal Barrier
by: Yanping Wang, et al.
Published: (2021-12-01)

Maintenance of intestinal homeostasis by mucosal barriers
by: Ryu Okumura, et al.
Published: (2018-04-01)

The impact of aging on intestinal mucosal immune function and clinical applications
by: Han Zheng, et al.
Published: (2022-11-01)

Influence of the intestinal microbiota on the formation and development of non-alcoholic fatty liver disease in children
by: L.K. Parkhomenko, et al.
Published: (2018-11-01)

Dihydromyricetin improves colonic mucosal barrier function in mice with metabolism-associated fatty liver disease
by: JIANG Ling, et al.
Published: (2023-01-01)

Glucosamine Improves Non-Alcoholic Fatty Liver Disease Induced by High-Fat and High-Sugar Diet through Regulating Intestinal Barrier Function, Liver Inflammation, and Lipid Metabolism
by: Feng Li, et al.
Published: (2023-10-01)

Clinical features of the comorbid course of non-alcoholic fatty liver disease and gallstone disease
by: N. A. Cherkashchenko, et al.
Published: (2020-09-01)

Features of the course of gallstone disease in patients with non-alcoholic fatty liver disease
by: N. A. Cherkashchenko, et al.
Published: (2020-02-01)

Non-Alcoholic Fatty Liver Disease, Bile Acids and Intestinal Microbiota
by: R. V. Maslennikov, et al.
Published: (2018-09-01)

<i>Lactobacillus plantarum</i> J26 Alleviating Alcohol-Induced Liver Inflammation by Maintaining the Intestinal Barrier and Regulating MAPK Signaling Pathways
by: Hongxuan Li, et al.
Published: (2022-12-01)

Effects of Polysaccharides from Rosa roxburghii Tratt Fruit on Ileal Mucosal Barrier Function in Mice with Non-alcoholic Fatty Liver
by: ZHANG Pan, WANG Lei, CHEN Jie, XU Fei
Published: (2023-02-01)

Berberine-Based Carbon Quantum Dots Improve Intestinal Barrier Injury and Alleviate Oxidative Stress in C57BL/6 Mice with 5-Fluorouracil-Induced Intestinal Mucositis by Enhancing Gut-Derived Short-Chain Fatty Acids Contents
by: Liang Wu, et al.
Published: (2023-02-01)

Cardiovascular Diseases and Non-Alcoholic Fatty Liver Disease: Relationship and Pathogenetic Aspects of Pharmacotherapy
by: A. V. Nelidova, et al.
Published: (2022-01-01)

Co-Cultures of <i>Lactobacillus acidophilus</i> and <i>Bacillus subtilis</i> Enhance Mucosal Barrier by Modulating Gut Microbiota-Derived Short-Chain Fatty Acids
by: Zhengjun Xie, et al.
Published: (2022-10-01)

Intestinal Microbiota Modulation in Obesity-Related Non-alcoholic Fatty Liver Disease
by: David Porras, et al.
Published: (2018-12-01)

Bifidobacterium lactis TY-S01 protects against alcoholic liver injury in mice by regulating intestinal barrier function and gut microbiota
by: Xi Shu, et al.
Published: (2023-07-01)

Lutein Prevents Liver Injury and Intestinal Barrier Dysfunction in Rats Subjected to Chronic Alcohol Intake
by: Suli Zhao, et al.
Published: (2023-02-01)

The Association of Altered Gut Microbiota and Intestinal Mucosal Barrier Integrity in Mice With Heroin Dependence
by: Jiqing Yang, et al.
Published: (2021-11-01)

Intestinal Mucosal Mast Cells: Key Modulators of Barrier Function and Homeostasis
by: Mercé Albert-Bayo, et al.
Published: (2019-02-01)

Fecal Microbiota Transplantation Protects the Intestinal Mucosal Barrier by Reconstructing the Gut Microbiota in a Murine Model of Sepsis
by: Xiaowei Gai, et al.
Published: (2021-09-01)

Protopine Alleviates Dextran Sodium Sulfate-Induced Ulcerative Colitis by Improving Intestinal Barrier Function and Regulating Intestinal Microbiota
by: Meishan Yue, et al.
Published: (2023-07-01)

Taurine Regulates the Expression of Interleukin −17/10 and Intestinal Flora and Protects the Liver and Intestinal Mucosa in a Nonalcoholic Fatty Liver Disease Rat Model
by: Zhu FL, et al.
Published: (2024-02-01)

The Effect of Probiotics (MCP<sup>®</sup> BCMC<sup>®</sup> Strains) on Hepatic Steatosis, Small Intestinal Mucosal Immune Function, and Intestinal Barrier in Patients with Non-Alcoholic Fatty Liver Disease
by: Mohamad Hizami Mohamad Nor, et al.
Published: (2021-09-01)

The Gut Barrier, Intestinal Microbiota, and Liver Disease: Molecular Mechanisms and Strategies to Manage
by: Julio Plaza-Díaz, et al.
Published: (2020-11-01)

Fecal microbiota transplantation and bacterial consortium transplantation have comparable effects on the re-establishment of mucosal barrier function in mice with intestinal dysbiosis
by: Ming eLi, et al.
Published: (2015-07-01)

The informative value of non-invasive liver fibrosis markers in patients with nonalcoholic fatty liver disease
by: M A Livzan, et al.
Published: (2016-12-01)

Polyphenols in the Fermentation Liquid of Dendrobium candidum Relieve Intestinal Inflammation in Zebrafish Through the Intestinal Microbiome-Mediated Immune Response
by: Xiaoyue Gong, et al.
Published: (2020-07-01)

Non-alcoholic fatty liver disease: Definition and subtypes
by: Seul Ki Han, et al.
Published: (2023-02-01)

Seabuckthorn polysaccharide combined with astragalus polysaccharide ameliorate alcoholic fatty liver by regulating intestinal flora
by: Jiayue Liu, et al.
Published: (2022-09-01)

Role of Goblet Cells in Intestinal Barrier and Mucosal Immunity
by: Yang S, et al.
Published: (2021-07-01)

Relationship between Mucosal Barrier Function of the Oviduct and Intestine in the Productivity of Laying Hens
by: Takahiro Nii
Published: (2022-04-01)

Changes of intestinal bacterial microbiota in coronary heart disease complicated with nonalcoholic fatty liver disease
by: Yiwen Zhang, et al.
Published: (2019-11-01)

Th22 cells and the intestinal mucosal barrier
by: Jieli Chen, et al.
Published: (2023-08-01)

Markers of Intestinal Permeability Are Rapidly Improved by Alcohol Withdrawal in Patients with Alcohol-Related Liver Disease
by: Finn Jung, et al.
Published: (2021-05-01)

Small nucleolar RNAs and SNHGs in the intestinal mucosal barrier: Emerging insights and current roles
by: Tian Yang, et al.
Published: (2023-04-01)

Mucosal Injuries due to Ribosome-Inactivating Stress and the Compensatory Responses of the Intestinal Epithelial Barrier
by: Yuseok Moon
Published: (2011-10-01)

Supplemental Xylooligosaccharide Modulates Intestinal Mucosal Barrier and Cecal Microbiota in Laying Hens Fed Oxidized Fish Oil
by: Jian-min Zhou, et al.
Published: (2021-02-01)